ReachMD

Be part of the knowledge.™

Genetics

660

LikeLikedUnlike

Episodes 1-15 of 181

- Marie-Claire Rowlinson, PhD, D(ABMM)
  Peer
0
Tackling TB
Tuberculosis Screening in At-Risk Patients During the COVID-19 Pandemic
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
5
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Mario R. Nacinovich, Jr., MSc
  Peer
- Lyudmila Bazhenova, MD
  Peer
0
Closing the Gaps in NSCLC
Targeting Oncogenic Drivers in NSCLC: Opportunities & Challenges
- Ivy Ka Man Law, PhD
  Peer
6
AudioAbstracts
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
3
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Carrie Guy, MS
  Peer
1
Medical Industry Feature
QNatal® Advanced: Understanding Prenatal Screening
- Fred R. Hirsch, MD, PhD
  Peer
0
Closing the Gaps in NSCLC
The Role of Oncogene Addiction in RET Mutations & Treatment Selection
- Jennifer Caudle, DO
  Peer
- Anjali Owens, MD
  Peer
2
Medical Breakthroughs from Penn Medicine
Gaining a Deeper Understanding of Inherited Cardiomyopathy
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
An Overview of RET Mutations in NSCLC
- Jennifer Caudle, DO
  Peer
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
Cases We Don’t Forget: Treating a Patient with RET-Mutated NSCLC
- Paul Doghramji, MD
  Peer
- Jonathan Stokes
  Peer
0
Clinician's Roundtable
Artificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
- Mario R. Nacinovich, Jr., MSc
  Peer
- Anthony Dragun, MD
  Peer
1
Breaking Boundaries in Breast Cancer
Oncologist Recommendations for Patients with Hereditary Breast Cancer
- Paul Doghramji, MD
  Peer
- Maria Escolar, MD, MS
  Peer
5
Clinician's Roundtable
Analyzing the Available Treatments for Adrenoleukodystrophy
- Paul P. Doghramji, MD, FAAFP
  Peer
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver

Loading...

Programs 12/1/20

Segment Chapters

Playlist:

Recommended